Back to discover
Disease

Hyperpigmentation

Late-stage therapeutic developmentEmerging research
1
Publications
15
Clinical trials
2023
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Skin Pigmentation Types, Causes and Treatment-A Review.

Research2023-06-18Molecules (Basel, Switzerland)

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q4 2026.
Major developments

Clinical trials

13 sponsors · 1 new · 1 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
15
All trials
3
Active
5
Late-stage
6
Completed
Late-stage studies
Recently completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

Skin Pigmentation Types, Causes and Treatment-A Review.

Molecules (Basel, Switzerland) · 2023 · 104 cites
Recent publications

Skin Pigmentation Types, Causes and Treatment-A Review.

Molecules (Basel, Switzerland) · 2023 · 104 cites
Major themes2
  • Hyperpigmentation1
  • Skin Pigmentation1
Leading journals1
  • Molecules (Basel, Switzerland)1
Leading researchers5
  • Jibreen A1
  • Karaman D1
  • Karaman R1
  • Thawabteh A1
  • Thawabteh AM1
Affiliations (unnormalised)3
  • Al-Quds University1
  • Birzeit University1
  • University of Basilicata1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.